These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11272372)

  • 1. Methods to improve dose uniformity for radioactive stents in endovascular brachytherapy.
    Amols HI
    Cardiovasc Radiat Med; 1999; 1(3):270-7. PubMed ID: 11272372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective analysis of catheter-based sources in intravascular brachytherapy.
    DeCunha J; Janicki C; Enger SA
    Brachytherapy; 2017; 16(3):586-596. PubMed ID: 28190783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endovascular brachytherapy in coronary arteries: the Rotterdam experience.
    Coen VL; Knook AH; Wardeh AJ; van der Giessen WJ; De Pan C; Sipkema D; Marijnissen JP; Sabaté M; den Boer A; Serruys PW; Levendag PC
    Cardiovasc Radiat Med; 2000; 2(1):42-50. PubMed ID: 11229062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-absorption correction for 32P, 198Au and 188Re stents: dose point kernel calculations versus Monte Carlo.
    Reynaert N; Häfeli UO
    Med Phys; 2001 Sep; 28(9):1883-97. PubMed ID: 11585219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monte Carlo calculations of dose distributions around 32P and 198Au stents for intravascular brachytherapy.
    Reynaert N; Verhaegen F; Taeymans Y; Van Eijkeren M; Thierens H
    Med Phys; 1999 Aug; 26(8):1484-91. PubMed ID: 10501047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a positron emitting V48 nitinol stent for intracoronary brachytherapy.
    Li AN; Eigler NL; Litvack F; Whiting JS
    Med Phys; 1998 Jan; 25(1):20-8. PubMed ID: 9472822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose effects of stents in intravascular brachytherapy for in-stent restenosis: a Monte Carlo calculation.
    Li XA
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):842-8. PubMed ID: 12573772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and intermediate-term results of (32)P radioactive beta-emitting stent implantation in patients with coronary artery disease: The Milan Dose-Response Study.
    Albiero R; Adamian M; Kobayashi N; Amato A; Vaghetti M; Di Mario C; Colombo A
    Circulation; 2000 Jan 4-11; 101(1):18-26. PubMed ID: 10618299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of stent design and delivery upon the long-term efficacy of radioisotope stents.
    Fischell TA; Hehrlein C; Fischell RE; Fischell DR
    J Invasive Cardiol; 2000 Mar; 12(3):162-7. PubMed ID: 10731287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European high-activity (32)P radioactive stent experience.
    Albiero R; Colombo A
    J Invasive Cardiol; 2000 Aug; 12(8):416-21. PubMed ID: 10953106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of endovascular brachytherapy physics for prevention of restenosis.
    Amols HI
    Cardiovasc Radiat Med; 1999; 1(1):64-71. PubMed ID: 11272358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose and dose rate effects of beta-particle emitting radioactive stents in a porcine model of restenosis.
    Carter AJ; Jenkins S; Sweet W; Bailey L; Jones R; Fischell TA; Virmani R
    Cardiovasc Radiat Med; 1999; 1(4):327-35. PubMed ID: 10828562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental results with endovascular irradiation via a radioactive stent.
    Carter AJ; Laird JR
    Int J Radiat Oncol Biol Phys; 1996 Nov; 36(4):797-803. PubMed ID: 8960505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advantages and limitations of radioactive stents.
    Hehrlein C; Kübler W
    Semin Interv Cardiol; 1997 Jun; 2(2):109-13. PubMed ID: 9546990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracoronary radiation with gamma wire inhibits recurrent in-stent restenosis.
    Waksman R; Bhargava B; Chan RC; Sherman W; Pisch J; Mintz GS; Lansky AJ; Ahmed J; Ricci NA; Liprie SF
    Cardiovasc Radiat Med; 2001; 2(2):63-8. PubMed ID: 11340009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Edge restenosis after implantation of high activity (32)P radioactive beta-emitting stents.
    Albiero R; Nishida T; Adamian M; Amato A; Vaghetti M; Corvaja N; Di Mario C; Colombo A
    Circulation; 2000 May; 101(21):2454-7. PubMed ID: 10831516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation dose from a phosphorous-32 impregnated wire mesh vascular stent.
    Janicki C; Duggan DM; Coffey CW; Fischell DR; Fischell TA
    Med Phys; 1997 Mar; 24(3):437-45. PubMed ID: 9089595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of stent on radiation dosimetry in an in-stent restenosis model.
    Fan P; Chiu-Tsao ST; Patel NS; Shih A; Ravi K; Sherman W; Tsao HS; Pisch J; Harrison LB
    Cardiovasc Radiat Med; 2000; 2(1):18-25. PubMed ID: 11229057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracoronary brachytherapy for the prevention of restenosis after percutaneous coronary revascularization.
    Sheppard R; Eisenberg MJ; Donath D; Meerkin D
    Am Heart J; 2003 Nov; 146(5):775-86. PubMed ID: 14597925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetry study for beta-radiation treatment of in-stent restenosis.
    Chu CH; Hsieh BT; Chen IJ; Chen WL; Lin UT
    Radiat Prot Dosimetry; 2009 Feb; 134(1):49-54. PubMed ID: 19376885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.